SCHEMBL10132487

SCHEMBL10132487

CCc1cccc(C(=O)[C@@H]2CCCN2C(=O)OC(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 5/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
NPC1 O15118 1/20 0.49
KLK7 P49862 1/20 0.48
NPSR1 Q6W5P4 2/20 0.47
LMNA P02545 1/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 2/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
USP30 Q70CQ3 3/20 0.45
EPHX2 P34913 1/20 0.45
MAPT P10636 1/20 0.44
HRH2 P25021 1/20 0.44
HRH1 P35367 1/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10132357 0.84 ALDH1A1 (0.56) UCHL1NPC1NPSR1LMNAALDH1A1
SCHEMBL10132254 0.84 UCHL1 (0.53) UCHL1MEN1KMT2ANPC1NPSR1
SCHEMBL5408443 0.83 NPC1 (0.57) UCHL1MEN1KMT2ANPC1KLK7
SCHEMBL3530509 0.83 NPC1 (0.57) UCHL1MEN1KMT2ANPC1KLK7
SCHEMBL10132515 0.82 UCHL1 (0.51) UCHL1MEN1KMT2ANPC1NPSR1
SCHEMBL8219918 0.82 UCHL1 (0.50) UCHL1MEN1KMT2ANPC1KLK7
SCHEMBL10132524 0.81 ALDH1A1 (0.56) UCHL1MEN1KMT2ANPC1NPSR1
SCHEMBL8215878 0.81 UCHL1 (0.49) UCHL1MEN1KMT2ANPC1NPSR1
SCHEMBL8222788 0.80 USP30 (0.53) UCHL1MEN1KMT2ANPC1NPSR1
SCHEMBL1795426 0.80 NPC1 (0.53) UCHL1MEN1KMT2ANPC1KLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374794-B1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2015-11-04 EP disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-2374794-A1 CYCLIC AMINE COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 EP disclosed
WO-2010074088-A1 CYCLIC AMINE COMPOUNDS 第一三共株式会社 (JP) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319468-A1 CYCLIC AMINE COMPOUNDS RYR2, CASR, RYR1 UCHL1 4548/4885MEN1 1659/4885KMT2A 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.